---

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

• Information for Healthcare Professionals: Sildenafil (marketed as Viagra and Revatio), Vardenafil (marketed as Levitra), Tadalafil (marketed as Cialis)
• FDA Announces Revisions to Labels for Cialis, Levitra and Viagra
• Questions and Answers about Viagra, Levitra, Cialis, and Revatio: Possible Sudden Hearing Loss
• Regulatory History for Cialis from Drugs@FDA

Historical Information

• Information for Healthcare Professionals: Tadalafil (marketed as Cialis)
• FDA Updates Labeling for Viagra, Cialis and Levitra for Rare Post-Marketing Reports of Eye Problems
• Questions and Answers on Cialis (tadalafil)